Freshfields Bruckhaus Deringer's patents team is described by a client as ‘one of the best in the Netherlands’, working closely with colleagues in London and Düsseldorf to coordinate major pharmaceutical patent litigation across Europe. The practice acts for clients bringing and defending infringement claims, while also assisting with FRAND licensing and SEPs. The practice is headed by Rutger Kleemans, who frequently pleads cases before Dutch and European IP courts, and Jelle Drok, who handles tech-related patent disputes. Ruben Laddé works closely with both practice heads, focusing primarily on contentious tech and telecoms patents matters, while Allard van Duijn is building up a strong pharmaceutical patent disputes practice.
Testimonials
Collated independently by Legal 500 research team.
'Very responsive team with engaging members, from junior associate to partner level, into which you are integrated seamlessly. It is a pleasure to work with such a team.'
'Next to the required knowledge and skills, they really ask the difficult questions and want to get to the details, also the weak spots, of the case. Rutger Kleemans is strategically very strong, while Ruben Laddé really gets to the bottom of a case, including the technical details.'
Key clients
- Moderna
- Novartis
Work highlights
- Coordinated global litigation on behalf of Moderna in regard to mRNA vaccines in their global dispute against Pfizer and BioNTech.
- Represented Novartis in PI and merits proceedings against Pharmathen concerning a method to manufacture octreotide acetate microparticles.